๐„๐ฅ๐ž๐ฏ๐š๐ญ๐ž ๐ฒ๐จ๐ฎ๐ซ ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ ๐ฆ๐‘๐๐€ ๐ฐ๐ข๐ญ๐ก ๐จ๐ฎ๐ซ ๐š๐๐ฏ๐š๐ง๐œ๐ž๐ ๐‡๐‘๐Œ๐’ ๐ž๐ฑ๐ฉ๐ž๐ซ๐ญ๐ข๐ฌ๐ž

๐„๐ฅ๐ž๐ฏ๐š๐ญ๐ž ๐ฒ๐จ๐ฎ๐ซ ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ ๐ฆ๐‘๐๐€ ๐ฐ๐ข๐ญ๐ก ๐จ๐ฎ๐ซ ๐š๐๐ฏ๐š๐ง๐œ๐ž๐ ๐‡๐‘๐Œ๐’ ๐ž๐ฑ๐ฉ๐ž๐ซ๐ญ๐ข๐ฌ๐ž
mRNA-based medicines are reshaping the future of healthcare, driving innovations in vaccines and personalised therapies. To ensure their stability, efficacy, and safety, a precise characterisation of Critical Quality Attributes (CQAs) such as sequence confirmation, 5' cap structure, and poly(A) tail length is crucial.

By working with QUALITY ASSISTANCE S.A. to streamline mRNA analytics, you will benefit from:

โœ… An extensive expertise in the ๐œ๐ก๐š๐ซ๐š๐œ๐ญ๐ž๐ซ๐ข๐ฌ๐š๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐œ๐จ๐ฆ๐ฉ๐ฅ๐ž๐ฑ ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ ๐ฆ๐จ๐๐š๐ฅ๐ข๐ญ๐ข๐ž๐ฌ
โœ… An access to ๐ฌ๐ญ๐š๐ญ๐ž-๐จ๐Ÿ-๐ญ๐ก๐ž-๐š๐ซ๐ญ ๐‡๐‘๐Œ๐’ ๐ญ๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐ž๐ฌ delivering high-precision and reproducible results
โœ… ๐“๐š๐ข๐ฅ๐จ๐ซ๐ž๐ ๐š๐ง๐š๐ฅ๐ฒ๐ญ๐ข๐œ๐š๐ฅ ๐ฐ๐จ๐ซ๐ค๐Ÿ๐ฅ๐จ๐ฐ๐ฌ addressing the specific challenges of mRNA therapeutic development

๐Ÿ”— Discover how we can support your mRNA development: https://lnkd.in/eR9eBcVu

LAB ANALYST - HPLC et/ou GC

๐Ÿšจ Nous recrutons : analyste de laboratoire HPLC et/ou GC ๐Ÿšจ

Vous รชtes spรฉcialisรฉ.e en chromatographie liquide et/ou gazeuse ? Vous avez une premiรจre expรฉrience dans un environnement rรฉglementรฉ et recherchez un poste au sein dโ€™une entreprise innovante ?

ร€ QUALITY ASSISTANCE S.A., sociรฉtรฉ belge de recherche sous contrat (CRO) de rรฉfรฉrence, nous recherchons un.e analyste de laboratoire pour rejoindre une รฉquipe dynamique et contribuer au dรฉveloppement de nouveaux mรฉdicaments.

๐ŸŽฏ Ce que nous recherchons :
Une expertise en HPLC et/ou GC
La connaissance du logiciel Empower
Une premiรจre expรฉrience dans un cadre rรฉglementaire
Une bonne maรฎtrise du franรงais et un niveau dโ€™anglais opรฉrationnel (B1/B2)

๐ŸŽ‰ Ce que nous offrons :
Un environnement professionnel collaboratif basรฉ sur le respect et lโ€™entraide
La possibilitรฉ de travailler sur des projets ร  fort impact dans le domaine pharmaceutique

Prรชt.e ร  donner un nouvel รฉlan ร  votre carriรจre ? โžก Postulez maintenant : https://lnkd.in/eUwZ_vNY

๐“๐ซ๐š๐ง๐ฌ๐Ÿ๐จ๐ซ๐ฆ๐ข๐ง๐  ๐€๐€๐•-๐›๐š๐ฌ๐ž๐ ๐ ๐ž๐ง๐ž ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ข๐ž๐ฌ ๐ฐ๐ข๐ญ๐ก ๐ฉ๐ซ๐ž๐œ๐ข๐ฌ๐ข๐จ๐ง

๐“๐ซ๐š๐ง๐ฌ๐Ÿ๐จ๐ซ๐ฆ๐ข๐ง๐  ๐€๐€๐•-๐›๐š๐ฌ๐ž๐ ๐ ๐ž๐ง๐ž ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ข๐ž๐ฌ ๐ฐ๐ข๐ญ๐ก ๐ฉ๐ซ๐ž๐œ๐ข๐ฌ๐ข๐จ๐ง
Adeno-associated viruses (AAVs) are driving innovation in gene therapy, but their ๐œ๐จ๐ฆ๐ฉ๐ฅ๐ž๐ฑ๐ข๐ญ๐ฒ ๐ฉ๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐ฌ ๐ฌ๐ข๐ ๐ง๐ข๐Ÿ๐ข๐œ๐š๐ง๐ญ ๐œ๐ก๐š๐ฅ๐ฅ๐ž๐ง๐ ๐ž๐ฌ in characterisation and quality control. ๐•๐ข๐ซ๐š๐ฅ ๐ ๐ž๐ง๐จ๐ฆ๐ž ๐ญ๐ข๐ญ๐ซ๐š๐ญ๐ข๐จ๐ง ๐ข๐ฌ ๐œ๐ซ๐ข๐ญ๐ข๐œ๐š๐ฅ for monitoring manufacturing processes and for ensuring precise drug dosing.

โš™ This application note, co-written with Oxford Biomedica, reports on the comparison of 2๏ธโƒฃ different emulsion-based digital PCR systems:
โ—พ The BioRad QX200
โ—พThe Stilla Naica platform

๐Ÿ‘‰ Read the full details and discover the conclusion:https://lnkd.in/eGyArKc7

At QUALITY ASSISTANCE S.A. Assistance, we are committed to supporting the development of innovative medicinal products by delivering reliable titration methods to assess the safety and efficacy of AAV-based therapies

hashtagGeneTherapy hashtagAAV hashtagDigitalPCR

๐—˜๐—บ๐—ฝ๐—ผ๐˜„๐—ฒ๐—ฟ๐—ถ๐—ป๐—ด ๐—ฏ๐—ถ๐—ผ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐—ฒ๐˜‚๐˜๐—ถ๐—ฐ๐˜€ ๐—ฑ๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜ ๐˜„๐—ถ๐˜๐—ต ๐—ฎ๐—ฑ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฑ ๐—›๐—ฅ๐— ๐—ฆ ๐˜€๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป๐˜€

๐—˜๐—บ๐—ฝ๐—ผ๐˜„๐—ฒ๐—ฟ๐—ถ๐—ป๐—ด ๐—ฏ๐—ถ๐—ผ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐—ฒ๐˜‚๐˜๐—ถ๐—ฐ๐˜€ ๐—ฑ๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜ ๐˜„๐—ถ๐˜๐—ต ๐—ฎ๐—ฑ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฑ ๐—›๐—ฅ๐— ๐—ฆ ๐˜€๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป๐˜€
Modern biotherapeutics like monoclonal antibodies and therapeutic proteins demand precise characterisation of critical quality attributes (CQAs) such as post-translational modifications, structural integrity, and charge variants to ensure safety, efficacy, and quality.

At QUALITY ASSISTANCE S.A., weโ€™re setting the benchmark with ๐—ถ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—›๐—ถ๐—ด๐—ต-๐—ฅ๐—ฒ๐˜€๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป ๐— ๐—ฎ๐˜€๐˜€ ๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐˜๐—ฟ๐—ผ๐—บ๐—ฒ๐˜๐—ฟ๐˜† (๐—›๐—ฅ๐— ๐—ฆ) ๐˜„๐—ผ๐—ฟ๐—ธ๐—ณ๐—น๐—ผ๐˜„๐˜€ that are GMP-compliant, reproducible, and tailored to your needs.

From ๐— ๐˜‚๐—น๐˜๐—ถ-๐—”๐˜๐˜๐—ฟ๐—ถ๐—ฏ๐˜‚๐˜๐—ฒ ๐— ๐—ผ๐—ป๐—ถ๐˜๐—ผ๐—ฟ๐—ถ๐—ป๐—ด (๐— ๐—”๐— ) to ๐—ฎ๐—ฑ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฑ ๐—ถ๐—ฐ๐—œ๐—˜๐—™ ๐—ณ๐—ฟ๐—ฎ๐—ฐ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป, our state-of-the-art solutions empower your biotherapeutics development, ensuring accuracy and compliance in regulated environments.

๐Ÿ”— Explore our expertise and discover why you can trust us to meet your biologics characterisation challenges : https://lnkd.in/esiGHfUP

Subscribe to